Charleston Laboratories, Inc.

ACTIVE

1001 N US Highway 1 Ste 500, 南卡罗来纳州查尔斯顿县, 南卡罗来纳州, United Stateswww.charlestonlabs.comPrivate11–50 employeesEstablished: 2007-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

50.0%

Phase 1

33.3%

Phase 2

16.7%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (6)

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Phase 2

Completed

interventional

Feb 2019475 participants

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

Phase 3

Completed

interventional

Aug 2017349 participants

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Phase 1

Completed

interventional

Jun 201540 participants

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

Phase 1

Completed

interventional

Nov 201420 participants

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

Phase 3

Completed

interventional

Oct 2014178 participants

Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

Phase 3

Completed

interventional

Jan 2013460 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations